cached image

Fei Peng, M.D, Ph.D

Affiliations: 
2018-2022 Department of Hepatology Jilin University First Hospital 
 2019-2020 Department of Molecular and cellular biology Baylor College of Medicine, Houston, TX 
 2020-2023 Department of Medicine Baylor College of Medicine, Houston, TX 
 2023- Department of Internal Medicine UT Southwestern Medical Center / The Johns Hopkins University School of Medicine 
Google:
"Fei Peng"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhong S, Yang W, Zhang Z, et al. (2023) Association between viral infections and glioma risk: a two-sample bidirectional Mendelian randomization analysis. Bmc Medicine. 21: 487
Zeng H, Yuan Q, Peng F, et al. (2023) A split and inducible adenine base editor for precise in vivo base editing. Nature Communications. 14: 5573
Xue Y, Gong Y, Li X, et al. (2023) Sex differences in paternal arsenic-induced intergenerational metabolic effects are mediated by estrogen. Cell & Bioscience. 13: 165
Lv X, Lu X, Cao J, et al. (2023) Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. Science (New York, N.Y.). 381: eabn4180
Jin Z, Peng F, Zhang C, et al. (2023) Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer. Heliyon. 9: e13195
Ma D, Yuan Q, Peng F, et al. (2023) Engineered PROTAC-CID Systems for Mammalian Inducible Gene Regulation. Journal of the American Chemical Society
Peng F, Li X, Xiao F, et al. (2022) Circadian clock, diurnal glucose metabolic rhythm, and dawn phenomenon. Trends in Neurosciences
Wang C, Peng F, Zhong B, et al. (2021) Metabolomic Analysis Reveals the Therapeutic Effects of MBT1805, a Novel Pan-Peroxisome Proliferator-Activated Receptor Agonist, on α-Naphthylisothiocyanate-Induced Cholestasis in Mice. Frontiers in Pharmacology. 12: 732478
Zhan MR, Gao XZ, Wang C, et al. (2021) Elevated soluble 4-1BB is associated with serum markers of hepatitis B virus in patients with chronic hepatitis B. World Journal of Clinical Cases. 9: 1619-1630
Liu M, Wu R, Liu X, et al. (2020) Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients. Journal of Hepatocellular Carcinoma. 7: 219-232
See more...